Key statistics
As of last trade, Armata Pharmaceuticals Inc (TG1N:MUN) traded at 2.12, 11.58% above the 52 week low of 1.90 set on Nov 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.94 |
---|---|
High | 2.12 |
Low | 1.94 |
Bid | 1.97 |
Offer | 2.12 |
Previous close | 1.92 |
Average volume | 11.11 |
---|---|
Shares outstanding | 36.18m |
Free float | 10.77m |
P/E (TTM) | -- |
Market cap | 75.62m USD |
EPS (TTM) | -1.24 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 18:39 GMT.
More ▼
Press releases
- Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting
- Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update
- Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia
- Armata Pharmaceuticals Announces Structural Biology Publication
- Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Armata Pharmaceuticals Announces Presentation at the 2024 Military Health System Research Symposium
More ▼